Regulations, few patients make New York medical marijuana a bad investment, Syracuse ...

Warning message

The subscription service is currently unavailable. Please try again later.

Executives from those companies that won licenses and that will set up manufacturing and dispensary operations shared their strategies to succeed: starting small, diversifying into related products and leveraging experience in other states.

New York state will set the prices marijuana products can be sold at, register patients and train and authorize physicians who can recommend the treatment. Torrens said the small number of patients who are likely eligible, between 120,000 and 125,000 people, will make it difficult for the companies to succeed.

For some of the business owners or investors, it might be more of a personal cause to give access to marijuana to those who need it, Torrens said. They could also be looking at the long-term payoff, as the state will likely protect the existing incumbents for a time while the number of people who can legally get marijuana expands.

Two of the three companies with medical...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.bizjournals.com/albany/news/2015/08/05/prof-new-york-medical-marijuana-a-bad-investment.html